ÂÜÀòÂÒÂ×

Ms. Brandano is responsible for managing all aspects of clinical trial operations for Qlaris Bio with a focus on the lead program, QLS-101.

Prior to joining Qlaris Bio, Ms. Brandano served as Vice President of Clinical Operations at EyeGate Pharmaceuticals, where she led all clinical operations for their lead and pipeline programs across small molecules and drug delivery devices. Before EyeGate Pharmaceuticals, she had held similar roles across clinical operations and management at Cato Research, a global CRO.

Ms. Brandano holds a BS in Biology from Emmanuel College.